Immix Biopharma Inc. (NASDAQ: IMMX)
$2.05
N/A ( 0% ) 52.0K
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
Market Data
Open
$2.05
Previous close
$2.05
Volume
52.0K
Market cap
$54.15M
Day range
$1.98 - $2.09
52 week range
$1.55 - $7.75
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 54 | Nov 13, 2023 |
4/a | Other | 1 | Nov 09, 2023 |
4/a | Other | 1 | Nov 09, 2023 |
4 | Insider transactions | 1 | Sep 18, 2023 |
4 | Insider transactions | 1 | Sep 15, 2023 |
4 | Insider transactions | 1 | Sep 14, 2023 |
4 | Insider transactions | 1 | Sep 12, 2023 |
4 | Insider transactions | 1 | Sep 11, 2023 |
4 | Insider transactions | 1 | Sep 08, 2023 |
4 | Insider transactions | 1 | Sep 06, 2023 |